Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Bevacizumab in Treating Patients With Kaposi's Sarcoma				Phase II				NCI-03-C-0110 NCI-5513, 5513, NCT00058136
	Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas				Phase II				MSKCC-07054 07-054, PFIZER-MSKCC-07054, NCT00474994
	Sorafenib in Treating Patients With Kaposi's Sarcoma				Phase I				NCI-06-C-0083 7048, NCI-7048, NCI-P6700, NCT00304122
	Dose Evaluation Study Of Oral Eltrombopag In Patients With Sarcoma Receiving The Adriamycin And Ifosfamide Regimen				Phase I				TRC105499 NCT00358540
	Antiretroviral Therapy With or Without Bortezomib or Combination Chemotherapy and Rituximab or Observation Only in Treating Patients With Castleman's Disease				No phase specified				NCI-04-C-0275 NCT00099073
	Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer				No phase specified				JHOC-J0685 NA_00003073, J0685, NCT00499733

| | | | | | | |

A Service of the National Cancer Institute